Dr Reddy’s Swallows Up Mayne’s US Generics Portfolio For $90m+

Indian Firm Strikes Deal For US Prescription Interests Of Australian Player

Big Fish Eats Little Fish M&A Concept
Dr Reddy’s has agreed to swallow up Mayne’s US prescription portfolio • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business